相关实验视频

Updated: Jul 9, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

一种与iTreg相关的新型特征用于肺腺癌的预后预测

Jian Zhang¹, Yan Li², Yue Yang³

¹Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.

|November 28, 2023

概括

研究人员确定了一种新的预后特征,该特征基于诱导性调节性T细胞 (iTreg) 相关的肺腺癌 (LUAD) 基因. 这种特征可以预测患者的结果和化疗敏感性,有助于为LUAD提供个性化治疗策略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
遗传学遗传学是一种遗传学.

背景情况:

肺腺癌 (LUAD) 是一种常见的癌症,通常在晚期被诊断出来,需要新的预后生物标志物.
诱导性调节性T细胞 (iTregs) 是关键的免疫抑制剂,对于维持免疫平衡至关重要.

研究的目的:

研究LUAD中iTreg相关基因的预后价值和治疗影响.
开发一个预测模型来预测LUAD患者的结果和治疗反应.

主要方法:

利用了LUAD患者数据的多数据库分析 (TCGA,GEO,TISIDB),包括RNA测序和临床特征.
采用单变量/多变量考克斯回归,加权相关联网络分析,以及用于签名构造的LASSO惩罚.
应用ESTIMATE算法和单细胞RNA测序用于免疫状态和化学敏感性预测.

主要成果:

确定了iTreg透作为LUAD的独立预后因素.
开发了七个基因特征 (GIMAP5,SLA,MS4A7,ZNF366,POU2AF1,MRPL12,COL5A1),将患者分为高风险和低风险组.
低风险小组表现出更好的预后和对化疗的潜在敏感性增加.

结论:

一个与iTreg相关的新型基因特征为LUAD预后提供了洞察力.
这种签名可以指导LUAD患者个性化化疗决策.
对iTreg作用的进一步研究可能会为LUAD发现新的治疗点.

关键词:

免疫微观环境免疫微环境可诱导的调节性T (iTreg) 细胞肺腺癌 (LUAD) 是一种肺腺癌.预后预后预后

更多相关视频

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...